How Does Amneal Pharmaceuticals Inc (AMRX) Stock Rank on Wall Street Tuesday?

Wall Street is positive on Amneal Pharmaceuticals Inc (AMRX). On average, analysts give the stock a Buy rating. The average price target is $6, which means analysts expect the stock to gain by 192.68% over the next twelve months. That average ranking earns the stock an Analyst Rating of 27, which is better than 27% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating AMRX a Buy today. Find out what this means to you and get the rest of the rankings on AMRX!

See Full AMRX Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Amneal Pharmaceuticals Inc Stock Today?

Amneal Pharmaceuticals Inc (AMRX) stock is trading at $2.05 as of 3:44 PM on Tuesday, Sep 27, a drop of -$0.12, or -5.32% from the previous closing price of $2.16. The stock has traded between $2.05 and $2.20 so far today. Volume today is light. So far 501,119 shares have traded compared to average volume of 1,441,660 shares. Click Here to get the full Stock Report for Amneal Pharmaceuticals Inc stock.